3 articles · Updated · erictopol.substack.com · Aug 12
Summary
Independent studies found that around age 50, blood-derived monocytes begin replacing the brain’s original microglia, especially in the hippocampus, overturning the view that brain aging is mainly steady tissue shrinkage.
Postmortem analyses spanning ages 20 to 100 linked that midlife shift to blood-brain barrier breakdown, inflammatory cytokine activity and an astrocyte energy crisis, while astrocyte loss itself appeared slow at about 0.2% a year.
The two teams used different lineage-tracing methods—multiomic methylation mapping and somatic-mutation tracking—to show the replacement cells come from bone marrow, with broader spread beyond the hippocampus and stronger effects in men.
One study also tied some mutated blood-cell clones in these replacement microglia to roughly 50% less Alzheimer’s-related pathology, suggesting peripheral immune cells could become targets for prevention or therapy.
Together, the findings add to evidence that human aging changes sharply rather than linearly and point to new strategies aimed at blocking inflammatory cell infiltration or engineering blood cells to protect the brain.